This site is not optimized for Internet Explorer 8 (or older).

Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.

CABG-related bleeding complications in real-life acute coronary syndrome patients treated with clopidogrel or ticagrelor

Thursday, October 9, 2014

Submitted by


Source Name: European Journal of Cardio-Thoracic Surgery


Emma C. Hansson, Helena Rexius, Mikael Dellborg, Per Albertsson, and Anders Jeppsson

This prospective observational study compares patients with coronary artery bypass grafting on aspirin and ticagrelor (n = 173) or on aspirin and clopidogrel (n = 232). Major bleeding complications occurred in 14.5% with ticagrelor and 13.8% with clopidogrel (p=0.89). 

No significant differences were observed, too, when the drugs were discontinued ≥5  or 2-4 days before surgery. A strong tendency to more bleeding complications in the ticagrelor group was found, however, when the drugs were given until 0–1 day before surgery.



Add comment

Log in or register to post comments